Stephanie Coffin
About Stephanie Coffin
Stephanie Coffin is a Regulatory Affairs Intern at Marker Therapeutics, Inc. and a PhD candidate at Baylor College of Medicine, specializing in genetic research for neurodegenerative disorders.
Current Role at Marker Therapeutics
Stephanie Coffin currently serves as a Regulatory Affairs Intern at Marker Therapeutics, Inc. since 2020. In this role, she assists in the preparation of regulatory documents for submission to both US and European governing agencies. Her work aims to bridge the gap between laboratory discoveries and market applications, enhancing the availability of therapeutics.
Education and Expertise
Stephanie Coffin is a PhD candidate in Genetics and Genomics at Baylor College of Medicine, a position she has held since 2017. She previously earned a Master of Science in Bioinformatics from Temple University, completing her studies from 2015 to 2017. Additionally, she holds a Bachelor of Science in Health and Human Physiology from the University of Iowa, which she obtained from 2009 to 2013.
Professional Background
Stephanie Coffin has held various positions in the field of research and project management. She worked as a Lab Manager at Children's Hospital of Philadelphia from 2014 to 2017 and as a Research Assistant at the University of Iowa from 2010 to 2014. Additionally, she served as a Project Manager at Enventure for three months in 2020 and as a Fellow at Mercury Fund for three months in 2019.
Previous Experience at Enventure
At Enventure, Stephanie Coffin held multiple roles, including Project Manager for the ENRICH initiative in 2020 and Business Development Manager for the Diligence Academy for six months in 2019. She also worked as a Fellow on the ENRICH project for three months in 2019.
Research Focus
Stephanie Coffin focuses on the development of therapeutics for neurodegenerative disorders through genetic research. Her academic and professional experiences contribute to her expertise in bridging laboratory research with practical therapeutic applications.